hemophagocytic syndrome

Showing 1 - 7 of 7

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hemophagocytic Syndrome Trial in Chongqing (cyclophosphamide, VP-16, Dexamethasone)

Recruiting
  • Hemophagocytic Syndrome
  • Chongqing, China
    The Second affiliated Hosptial of Chongqing medical University
Jun 28, 2023

Prospective Validation of the OHI Index

Recruiting
  • HLH
  • +4 more
    • Kfar Saba, Israel
    • +1 more
    May 21, 2023

    Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, Acute Myeloid Leukemia Trial in Houston (iCaspase9-transduced T cells,

    Active, not recruiting
    • Acute Lymphoblastic Leukemia
    • +9 more
    • iCaspase9-transduced T cells
    • AP1903
    • Houston, Texas
    • +1 more
    Jul 22, 2022

    Granulomatosis With Polyangiitis, Hemophagocytic Syndrome Trial in Changchun (Meperizumab injection, NUCALA®)

    Not yet recruiting
    • Granulomatosis With Polyangiitis
    • Hemophagocytic Syndrome
    • Changchun, Jilin, China
      Affiliated Hospital of Changchun University of Traditional Chine
    Apr 28, 2022

    Children and Adult Hemophagocytic Syndrome (HLHa)

    Completed
    • Hemophagocytic Syndrome
    • Identification of biological markers
    • Paris, France
      Clinical Research Unit
    Nov 19, 2021

    Hemophagocytic Syndrome, T/NK-Cell Lymphoma Trial in Zhengzhou (Ruxolitinib, Etoposide, Dexamethasone, Gemcitabine,

    Recruiting
    • Hemophagocytic Syndrome
    • T/NK-Cell Lymphoma
    • Ruxolitinib, Etoposide, Dexamethasone, Gemcitabine, Pegaspargase, cis-platinum
    • Zhengzhou, Henan, China
      Oncology Department of The First Affiliated Hospital of Zhengzho
    Aug 3, 2021

    Hemophagocytic Syndrome Trial in Beijing (PEG-rhG-CSF, rhG-CSF)

    Not yet recruiting
    • Hemophagocytic Syndrome
    • Beijing, China
      Beijing Friendship Hospital
    Aug 3, 2020